These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2291522)

  • 1. ADP receptors in platelets.
    Colman RW
    Ann N Y Acad Sci; 1990; 603():198-209; discussion 209-10. PubMed ID: 2291522
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggregin: the platelet receptor mediating activation by ADP.
    Colman RW; Puri RN; Zhou FX; Colman RF
    Prog Clin Biol Res; 1988; 283():263-77. PubMed ID: 3211953
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of ADP receptors.
    Cusack NJ; Hourani SM; Welford LA
    Adv Exp Med Biol; 1985; 192():29-39. PubMed ID: 3010670
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood cells: an historical account of the roles of purinergic signalling.
    Burnstock G
    Purinergic Signal; 2015 Dec; 11(4):411-34. PubMed ID: 26260710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet membrane glycoproteins and their role in the receptor activity of blood platelets].
    Pawłowska Z; Cierniewski C; Krzesłowska J; Koziołkiewicz W
    Postepy Biochem; 1988; 34(3):183-207. PubMed ID: 2855751
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation.
    Timmons S; Hawiger J
    Trans Assoc Am Physicians; 1986; 99():226-35. PubMed ID: 3496699
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple P2 receptor subtypes on platelets: a new interpretation of their function.
    Kunapuli SP
    Trends Pharmacol Sci; 1998 Oct; 19(10):391-4. PubMed ID: 9803826
    [No Abstract]   [Full Text] [Related]  

  • 10. Control and interrelation of aggregation and secretion; the roles of Ca2+, diacylglycerol and thromboxane with particular reference to ADP stimulation.
    Hallam TJ; Simpson AW; O'Connor N; Rink TJ
    Adv Exp Med Biol; 1985; 192():145-62. PubMed ID: 3010663
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA; Hourani SM
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of nucleotide affinity analog 5'-p-fluorosulfonylbenzoyladenosine with platelet ADP receptor: aggregin.
    Figures WR; Scearce LM; Colman RF; Colman RW
    Methods Enzymol; 1992; 215():143-55. PubMed ID: 1435320
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
    Jarvis GE; Atkinson BT; Snell DC; Watson SP
    Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP induces desensitisation of equine platelet aggregation responses: studies using ADP beta S, a stable analogue of ADP.
    Poole AW; Heath MF; Evans RJ
    Res Vet Sci; 1993 Mar; 54(2):235-43. PubMed ID: 8460266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Wright-Schulte Lecture.
    Verstraete M
    Haemostasis; 1982; 12(4):317-36. PubMed ID: 6295896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
    Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
    Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIa.
    Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
    Trans Assoc Am Physicians; 1986; 99():39-45. PubMed ID: 3603928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glycoprotein IIb-IIIa complex in ristocetin-stimulated platelets as revealed by a monoclonal antibody.
    Hato T
    Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):129-37. PubMed ID: 3591232
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of GPIIb-IIIa complex ligands on calcium ion movement and cytoskeleton organization in activated platelets.
    Sinigaglia F; Bisio A; Torti M; Balduini CL; Bertolino G; Balduini C
    Biochem Biophys Res Commun; 1988 Jul; 154(1):258-64. PubMed ID: 3395329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.